Header image

Petřík Miloš Assoc. Prof., PharmDr., Ph.D.
Journals
Modulating the pharmacokinetic profile of Actinium-225-labeled macropa-derived radioconjugates by dual targeting of PSMA and albumin.
Theranostics.
2022,
12(17),
7203-7215,
ISSN: 1838-7640,
PMID: 36438496,
Preparation, In Vitro Affinity, and In Vivo Biodistribution of Receptor-Specific 68Ga-Labeled Peptides Targeting Vascular Endothelial Growth Factor Receptors.
Bioconjugate Chemistry.
2022,
33(10),
1825-1836,
ISSN: 1043-1802,
PMID: 36197842,
Open positions
Project: | Preclinical development of molecular imaging agents |
---|---|
Supervisors: | Petřík Miloš Assoc. Prof., PharmDr., Ph.D. |
Available: | 2 |
Intended for: | Doctoral training |
Project: | Preclinical development of substances for molecular imaging |
---|---|
Supervisors: | Petřík Miloš Assoc. Prof., PharmDr., Ph.D. |
Available: | 1 |
Intended for: | Doctoral training |
Summary: | 1 place in full-time study |
Project: | In vivo imaging of 68Ga labelled biomolecules |
---|---|
Supervisors: | Petřík Miloš Assoc. Prof., PharmDr., Ph.D. |
Available: | 1 |
Intended for: | Bachelor training |
Project: | Radiolabelled siderophores for infection imaging |
---|---|
Supervisors: | Petřík Miloš Assoc. Prof., PharmDr., Ph.D. |
Available: | 1 |
Intended for: | Master training |
Project: | Radiolabelled peptides for cancer imaging |
---|---|
Supervisors: | Petřík Miloš Assoc. Prof., PharmDr., Ph.D. |
Available: | 1 |
Intended for: | Master training |